Humabs BioMed AG

Name: Humabs BioMed AG
Telephone: +41 91 825 63 80

Swiss Biotech Association

Member

Humabs BioMed, a subsidiary of Vir Biotechnology is a leading Swiss antibody therapeutics company that discovers and develops superior antibodies directly derived from individuals who have successfully overcome major diseases.

http://www.vir.bio
+41 91 825 63 80
info@humabs.ch
Filippo Riva

Location

Via dei Gaggini 3, 6500 Bellinzona, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2004
Number of employees in Switzerland

20-49

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

TissueLabs Sagl

TissueLabs is the platform for creating organs and tissues in the lab. We offer biomaterials, equipment, and services to support tissue engineering and regenerative medicine. Our mission is to fabricate lab-grown tissues and organs, for both research and therapeutic applications.
Via Cantonale 18

Member

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

Member

Laevoroc Oncology AG

Founded in 2019, Laevoroc is a privately-owned, Swiss oncology group of companies that leverages word-class technologies, our oncology expertise and extensive R&D and commercial experience to approach innovation in cancer therapeutics in a way that combines the pragmatic with the visionary.
Hünenberg

Member